Needham & Company
-
Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD & DME Drug Development Summit
-
Clearside Biomedical to Present at the Needham Virtual Healthcare Conference
-
Needham & Company Downgrades Clearside Biomedical (CLSD) to Hold
-
Clearside Biomedical to Present at the 18th Annual Needham Healthcare Conference
-
Clearside Biomedical to Present at the 18th Annual Needham Healthcare Conference
-
Clearside Biomedical (CLSD) PT Lowered to $4 at Needham & Company
-
Pre-Open Movers 11/05: (DWCH) (INFI) (TVPT) Higher; (CLSD) (SYY) (RACE) Lower (more...)
-
Clearside Biomedical to Present at the 17th Annual Needham Healthcare Conference
-
Clearside Biomedical to Present at the 17th Annual Needham Healthcare Conference
-
Clearside Biomedical (CLSD) Prices 6.54M Shares at $13
-
Clearside Announces Pricing of Public Offering of Common Stock
-
Clearside Announces Pricing of Public Offering of Common Stock
-
UPDATE: Clearside Biomedical (CLSD) Announces Proposed $75M Common Share Offering
-
Clearside Announces Proposed Public Offering of Common Stock
-
Clearside Announces Proposed Public Offering of Common Stock
-
Clearside Biomedical (CLSD) PT Raised to $22 at Needham & Company
-
Clearside Biomedical, Inc. to Present at the 16th Annual Needham Healthcare Conference
-
Clearside Biomedical (CLSD) PT Lowered to $18 at Needham & Company Following 4Q Report
-
Needham & Company Starts Clearside Biomedical (CLSD) at Buy
-
Clearside Biomedical (CLSD) IPO Opens Up 14%
-
Clearside Biomedical (CLSD) Prices 7.2M Common Stock IPO at $7/Share
-
Clearside Biomedical, Inc. Announces Pricing of Initial Public Offering